The increasing demand for ketamine, mainly for emotional ailments, presents significant challenges regarding such provision and private transport within the United States. Strict national regulations govern this process, requiring conformity from suppliers. Furthermore, preserving patient anonymity through meticulous packaging and compliant deliver